Frank Takkinen
Stock Analyst at Lake Street
(0.92)
# 3,979
Out of 5,154 analysts
75
Total ratings
26.47%
Success rate
-15.96%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $21.14 | +136.52% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.37 | +306.39% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.75 | -26.32% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $10.61 | +277.00% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.54 | +76.21% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $3.71 | +223.45% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $28.55 | +40.11% | 2 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.98 | +309.42% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $0.90 | +234.60% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $2.02 | +98.02% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.09 | +450.46% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $2 | $1.07 | +86.92% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $62.99 | +138.13% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.83 | +121.61% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $8.25 | +69.70% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.80 | +27.12% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $15.30 | +69.93% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $10.00 | +200.00% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.20 | +222.58% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.64 | +204.88% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $37.04 | -19.01% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.65 | +822.37% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.05 | +95.12% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $14.03 | -14.47% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.12 | +188.46% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.13 | +287.41% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $10.42 | +2,557.39% | 2 | Jan 18, 2023 |
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $21.14
Upside: +136.52%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.37
Upside: +306.39%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.75
Upside: -26.32%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $10.61
Upside: +277.00%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.54
Upside: +76.21%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $3.71
Upside: +223.45%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $28.55
Upside: +40.11%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.98
Upside: +309.42%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.90
Upside: +234.60%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.02
Upside: +98.02%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.09
Upside: +450.46%
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.07
Upside: +86.92%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $62.99
Upside: +138.13%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.83
Upside: +121.61%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $8.25
Upside: +69.70%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.80
Upside: +27.12%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $15.30
Upside: +69.93%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $10.00
Upside: +200.00%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $6.20
Upside: +222.58%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.64
Upside: +204.88%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $37.04
Upside: -19.01%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.65
Upside: +822.37%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.05
Upside: +95.12%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $14.03
Upside: -14.47%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.12
Upside: +188.46%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.13
Upside: +287.41%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $10.42
Upside: +2,557.39%